Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-17 4:06 pm Unchanged | 13G | Cardiff Oncology Inc. CRDF | COMMODORE CAPITAL LP | 0 0.000% | 0 (Unchanged) | View |
| 2024-12-11 4:05 pm Purchase | 13G | Neurogene Inc. NGNE | COMMODORE CAPITAL LP | 800,000 5.400% | 800,000 (New Position) | View |
| 2024-11-14 4:10 pm Sale | 13G | Vera Therapeutics Inc. VERA | COMMODORE CAPITAL LP | 2,475,000 4.500% | -1,425,000 (-36.54%) | View |
| 2024-11-14 4:05 pm Sale | 13G | MERUS N V COM MRUS | COMMODORE CAPITAL LP | 3,350,000 4.900% | -1,397,373 (-29.43%) | View |
| 2024-11-14 4:05 pm Purchase | 13G | Enliven Therapeutics Inc. ELVN | COMMODORE CAPITAL LP | 4,100,000 8.700% | 1,198,184 (+41.29%) | View |
| 2024-11-14 4:05 pm Sale | 13G | Vera Therapeutics Inc. VERA | COMMODORE CAPITAL LP | 3,900,000 7.300% | -1,550,000 (-28.44%) | View |
| 2024-11-14 4:05 pm Sale | 13G | C4 THERAPEUTICS INC CCCC | COMMODORE CAPITAL LP | 3,410,384 4.800% | -389,616 (-10.25%) | View |
| 2024-11-14 4:05 pm Purchase | 13G | Mind Medicine (MindMed) Inc. MNMD | COMMODORE CAPITAL LP | 8,176,721 9.900% | 2,343,388 (+40.17%) | View |
| 2024-11-14 4:05 pm Sale | 13G | Celcuity Inc. CELC | COMMODORE CAPITAL LP | 2,217,982 5.900% | -274,904 (-11.03%) | View |
| 2024-11-14 4:05 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | COMMODORE CAPITAL LP | 3,350,000 4.960% | 3,350,000 (New Position) | View |
| 2024-11-14 4:05 pm Unchanged | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | COMMODORE CAPITAL LP | 0 0.000% | 0 (Unchanged) | View |
| 2024-11-14 4:05 pm Purchase | 13G | NKARTA INC NKTX | COMMODORE CAPITAL LP | 4,662,073 6.600% | 1,932,073 (+70.77%) | View |
| 2024-11-14 4:05 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 10,497,990 9.300% | 4,325,904 (+70.09%) | View |
| 2024-11-14 4:05 pm Purchase | 13G | SPYRE THERAPEUTICS, INC SYRE | COMMODORE CAPITAL LP | 1,988,084 3.900% | 54,000 (+2.79%) | View |
| 2024-11-14 4:05 pm Sale | 13G | ADICET BIO INC ACET | COMMODORE CAPITAL LP | 0 0.000% | -4,250,000 (Position Closed) | View |
| 2024-10-25 4:05 pm Purchase | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | COMMODORE CAPITAL LP | 400,000 9.000% | 400,000 (New Position) | View |
| 2024-10-17 4:05 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | COMMODORE CAPITAL LP | 6,807,507 9.990% | 6,807,507 (New Position) | View |
| 2024-06-21 4:05 pm Purchase | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | COMMODORE CAPITAL LP | 750,000 7.000% | 750,000 (New Position) | View |
| 2024-04-19 4:05 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | COMMODORE CAPITAL LP | 38,906,673 6.600% | 38,906,673 (New Position) | View |
| 2024-03-21 4:05 pm Purchase | 13G | Mind Medicine (MindMed) Inc. MNMD | COMMODORE CAPITAL LP | 5,833,333 8.300% | 5,833,333 (New Position) | View |